abstract |
FIELD: pharmaceuticals.SUBSTANCE: present invention relates to new therapeutic tools capable of treating infectious diseases, in particular to a novel pharmaceutical composition, containing an immunoglobulin enriched IgM preparation for use in the adjunctive treatment of severe community-acquired pneumonia (sCAP).EFFECT: treatment of severe community-acquired pneumonia is suggested.49 cl, 11 dwg, 5 tbl, 7 ex |